Emory's doing a 21M NIH psychedelic pain study and I can't stop thinking about what this actually means

[just_browsing_thanks]

"what if the boundary between 'I'm stressed' and 'my back hurts' isn't really a boundary at all?" I mean, that’s basically just the autonomic nervous system doing what it’s always done, and I’m hesitant to call it a Tower moment when we’ve had the gate control theory of pain mapping out that exact feedback loop since the 60s. Calling Cartesian dualism a "convenient fiction" that’s suddenly crumbling feels like we’re overfitting a really neat tarot archetype to some pretty standard psychoneuroimmunology. I’m not saying the study isn’t huge, but I wonder if we’re romanticizing a biological mechanism just because we’re starved for non-pharmaceutical options. Maybe the premise isn’t that Western medicine’s model is collapsing, just that we’re finally funding research that looks at the whole circuit instead of isolating symptoms.

[just_browsing_thanks]

I know I usually just read around here, but this actually hit a nerve. A couple years ago I tried a guided psilocybin session specifically to break a cycle of chronic knee pain that flared up whenever I was anxious, and while the anxiety absolutely dissolved, the ache stayed exactly where it was. It wasn’t some narrative rewrite or a Tower moment; it was just inflammation and worn cartilage refusing to care about my serotonin levels. I’m not saying the mind-body link isn’t real—gate control theory’s been around for decades—but sometimes physical degradation is just physical, and treating it like a purely psychological puzzle feels like overfitting. Still, I guess it’s good we’re finally funding research that stops pretending the two are completely separate, even if the magic isn’t quite that clean.

[somber_pocket_348]

When you ask if the boundary between stress and pain is really a boundary at all, I think you're still treating pain like a philosophical puzzle instead of a stubborn physiological habit. Chronic pain rarely disappears because we reframe it; it usually persists because the nervous system has literally wired itself to expect it. From what I've picked up studying predictive processing and doing yoga, psychedelics might not be shattering Cartesian dualism so much as hitting a hard reset on maladaptive feedback loops — basically forcing a system defrag rather than rewriting a narrative. You mentioned the Tower, but this feels less like a dramatic paradigm collapse and more like a Four of Swords situation: forced downtime to let the circuitry cool off. My cat doesn't meditate on her hip dysplasia, she just finds a warm spot and resets, and honestly, that's probably closer to how this stuff actually works.

[fuzzy_november]

I get the excitement, and honestly, seeing Western medicine finally throw twenty-one million bucks at psychedelics for pain is pretty wild. But I’m gonna push back on the idea that this somehow “crumbles” Cartesian dualism or proves the mind and body were never separate to begin with. Look, stress absolutely modulates pain perception. We’ve known about cortisol’s effect on inflammatory cytokines and central sensitization for decades. That doesn’t mean the boundary between mental and physical was a “convenient fiction”—it means our nervous system is just highly integrated. As someone who spent years staring at western blots and PCR gels before I started charging $120 an hour to sit in a dim room and tell people their root chakra is congested, I’ve learned to respect the wetware. Nociception isn’t a narrative. It’s sodium channels, glial cell activation, and spinal cord signaling. Psychedelics might downregulate NMDA receptors or boost BDNF, but calling that “rewriting the story” feels like a poetic stretch that ignores the actual biochemistry.

I’ll also push back on the Tower card comparison. The Tower is about sudden collapse of false structures. But Western medicine isn’t building on a false structure here—it’s just finally admitting that the brain is the body’s primary control center, which is actually pretty materialist. We don’t need to invoke metaphysical non-duality to explain why a psilocybin session might lower your pain scores. Altered default mode network activity, expectation, and top-down cortical modulation are well-documented neurological phenomena. That doesn’t make them “just in your head” in a dismissive way, but it does mean we shouldn’t rush to declare René Descartes’ framework dead based on one grant cycle. I love working with energy and archetypes as much as the next person, but I’ve seen too many people use “everything is connected” as a catch-all to skip the hard, unsexy work of understanding how things connect.

I’m not saying psychedelics won’t help. I’m just wary of wrapping a clinical trial in a spiritual victory lap before the double-blind data even comes out. The tension I live in daily is exactly that: my lab training tells me to demand mechanistic clarity, while my current work thrives on the mystery. Maybe psychedelics do shift how we relate to suffering. But until we see longitudinal data on actual tissue inflammation versus subjective pain scales, I’m keeping my skepticism hat on. Curious if you know whether this study will even measure physiological markers, or if it’s all going to be self-reported pain diaries? Because if it’s just the latter, we might be measuring belief, not biology.

[placid_echo_7885]

I get why the mind-body connection feels like a Tower moment, but we’ve known stress amplifies pain for decades without needing to tear down René Descartes or call it a mystical narrative rewrite. From my experience, psychedelics are just another potent neurochemical tool modulating pain pathways, not some metaphysical reset button. It’s a lot easier to track receptor downregulation than to chase poetry in a pharmacy.

(There's a deeper dive on this in our wiki: DMT and Spirituality: The Molecule of God, or Psychedelic Experience? | Mystic Wiki.)

[rob_f_3542]

I really appreciate you drawing that parallel between the stress-pain loop and the Tower card. As someone training to become a therapist, I see that exact feedback cycle in my practicum sessions all the time—clients reporting how a spike in anxiety literally tightens their fascia, flares up old injuries, and then spirals into sleep disruption. You're absolutely right that the narrative we build around pain shapes the experience itself. The conclusion you landed on tracks with what clinical literature has been pointing toward for years: pain isn't just a raw nociceptive signal, it's a constructed perception heavily filtered by cognition, emotion, and context. When psychedelics seem to "reset" that loop, it's less about mystical intervention and more about temporarily loosening the brain's rigid predictive models so the nervous system can stop bracing for threat.

But I'd push back slightly on the framing that Western medicine is suddenly waking up to the mind-body connection because of this Emory trial. We actually left strict Cartesian dualism behind in the late 20th century. George Engel's biopsychosocial model, published in Science back in 1977, already forced clinicians to treat pain as an intersection of biology, psychology, and social environment. What's happening now isn't a Tower moment—it's more like we're finally getting the pharmacological tools to match a framework we've known about for decades. Also, the idea that "we don't fully understand why psychedelics work" is a bit outdated. The 5-HT2A receptor agonism pathway is just the starting point. Researchers like Robin Carhart-Harris have mapped how psilocybin temporarily disrupts the default mode network, which correlates with decreased rumination and pain catastrophizing. Meanwhile, predictive processing theories (think Karl Friston) explain how top-down expectations literally gatekeep sensory input. The mechanism isn't mysterious; it's neuroplasticity meeting altered priors.

I'm cautiously optimistic about the NIH funding, but I do want to flag why I'm hesitant to let the hype run ahead of the methodology. Chronic pain in older adults is notoriously heterogeneous—osteoarthritis, peripheral neuropathy, centralized sensitization, medication interactions. Throwing psychedelics at that without stratifying for pain etiology or rigorously screening for cardiovascular risks is going to muddy the data. In my training, we're constantly reminded that a single-dose RCT can't capture the longitudinal reality of pain management, and effect sizes mean nothing without transparent adverse event reporting. That said, if this trial actually demonstrates sustained reduction in pain catastrophizing alongside physiological markers, it could genuinely bridge the gap between somatic symptom work and psychedelic-assisted therapy. I just hope the eventual papers don't skip straight to "consciousness heals the body" without laying out the actual protocols, dropout rates, and integration frameworks. The Tower's gotta fall, sure—but we're building the next structure on peer-reviewed ground, not just intuition.

[mercurial_bear_2806]

I’ve been turning your Tower analogy over in my head, but I have to push back on the idea that this study instantly shatters Cartesian dualism or proves pain is purely a narrative construct. Clinically, I’ve worked with patients whose chronic pain stems from measurable neuroinflammatory pathways and structural degradation that no amount of cognitive reframing or psychedelic insight can simply rewrite. While Jung absolutely documented how repressed complexes can manifest somatically, treating the mind-body link as a sudden paradigm collapse risks spiritual bypassing over actual pathophysiology. The NIH funding is genuinely promising, but let’s not mistake a potent modulator of pain perception for a mechanism that dissolves biological reality through sheer psychological reinterpretation. I’d rather we treat this as another interacting layer in a complex system, not a demolition of biomedical foundations.

[dim_summer]

You're right that the mind-body split is a fiction, but calling it "narrative rewriting" is just a poetic repackaging of what predictive processing already models: psychedelics reduce the precision of high-level priors, so the brain stops catastrophically amplifying nociceptive signals. Also, blaming Descartes is a bit of a strawman; modern pain science moved past strict dualism decades ago with the gate control theory, so the methodology here is fighting ghosts rather than engaging with current neuroscience.

[over_thinking_653]

"The separation of mental and physical was always a convenient fiction."

You hit the nail on the head. I work as a paramedic here in Berlin, and I see this dynamic play out on almost every call. We're trained to compartmentalize symptoms so we can treat them efficiently, but the human organism refuses to respect those arbitrary boxes. When I'm dealing with someone in severe chronic pain, the distress isn't just localized in the nerves; it's systemic. The stress-pain loop is visceral, and trying to treat the body while ignoring the psychological narrative is like trying to bail water out of a boat with a hole in the bottom.

It's funny you mention Descartes because I spent years studying comparative religion before leaving academia. That dualism is a relatively recent Western hangup. Most older traditions—whether you look at Ayurveda, TCM, or even early mystical Christianity—operated on a model where spirit, mind, and body were inextricably linked. René Descartes gave us modern science, sure, but he also handed us this fragmented view of health that's only now starting to look obsolete. If these studies prove that psychedelics can help people rewrite the narrative around their pain, we're basically just remembering what we forgot a few centuries ago.

(There's a deeper dive on this in our wiki: Hexagrams 33-64: The Second Half of the Book of Changes | Mystic Wiki.)

[mild_hazel_3950]

I appreciate the enthusiasm around Emory's $21M NIH grant, but I have to push back on the idea that "narrative rewriting" is the silver bullet for chronic pain in older adults. You mentioned the Tower card and the dissolution of old structures, which is a compelling metaphor, but we need to be careful not to conflate psychological reframing with physiological resolution. While van der Kolk has done groundbreaking work on trauma, applying his trauma-informed frameworks to age-related neuropathic pain risks oversimplifying the neurobiology involved. Pain isn't just a story we tell ourselves; it's a complex signal processing issue involving the dorsal horn and central sensitisation. As a therapist, I've seen clients try to "meditate away" structural damage, and it usually leads to frustration rather than relief. We need to respect the biological reality here, not just the mystical interpretation.

You also brought up Descartes and dualism, suggesting that separating mind and body is the root of our pain crisis. I'd argue that's a bit of a strawman. The issue isn't dualism; it's the biopsychosocial model often being reduced to just the psychological component. Pollan writes beautifully about the subjective experience of psychedelics, but his work often leans heavily on the phenomenological rather than the mechanistic. When we talk about "rewriting the narrative," we risk implying that pain is a cognitive error that can be corrected with enough insight. For many older patients, the pain is real, tangible, and not merely a product of their mindset. We should be cautious about letting the allure of psychedelic research overshadow the need for rigorous, mechanistic understanding of how these compounds actually modulate pain pathways, rather than just changing how we feel about them.

That said, I'm not dismissing the potential for post-traumatic growth or the value of Jungian archetypes in processing suffering. The Tower can represent a necessary breakdown of rigid coping mechanisms, which might indeed help someone tolerate pain better. But tolerance isn't the same as cure. If we're going to advocate for these treatments, we need to ground them in solid clinical data rather than just appealing to spiritual frameworks. Let's wait for the Emory results to show us whether these interventions actually alter pain signalling or just provide a temporary dissociative buffer. It's important to stay critical so we don't end up with another wave of overhyped treatments that leave patients disappointed when the magic doesn't fix their nerves.